Vector Characterization Methods for Quality Control Testing of Recombinant Adeno-Associated Viruses
The DOI matches its Crossref record; 21 of the 22 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV)-based vectors expressing therapeutic gene products have shown great promise for human gene therapy. A major challenge for translation of promising research to clinical development is the establishment of appropriate quality control (QC) test methods to characterize clinical grade AAV vectors. This chapter focuses on QC testing, providing an overview of characterization methods appropriate for clinical vectors prepared for early phase clinical studies, and detailed descriptions for selected assays that are useful to assess AAV vector safety, potency, and purity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Quality control includes testing the rAAV production on safety (sterility, viral contaminants, mycoplasma, endotoxins, bacterial and fungistatic activity), appearance, pH, osmolarity, potency (viral genome titer, infectivity, expression), purity, and vector genome identity [258].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [258]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Maguire, A. M., High, K. A., Auricchio, A., Wright, J. F., Pierce, E. A., Testa, F., Mingozzi, F., Bennicelli, J. L., Ying, G.-S., Rossi, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61836-5 · Cited by 865
Self-citationUse of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
Muzyczka, N. (1992) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-75608-5_5 · Cited by 754
Samulski, R. J., Chang, L. S., & Shenk, T. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 743
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Samulski, R. J., Chang, L. S., & Shenk, T. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449
Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c29356 · Cited by 445
Self-citationClark, K. R., Liu, X., Mcgrath, J. P., & Johnson, P. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950018427 · Cited by 305
Cell Lines for the Production of Recombinant Adeno-Associated Virus
Clark, K. R., Voulgaropoulou, F., Fraley, D. M., & Johnson, P. R. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.10-1329 · Cited by 257
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
Sommer, J. Ü. M., Smith, P. H., Parthasarathy, S., Isaacs, J., Vijay, S., Kieran, J., Powell, S. K., McClelland, A., & Wright, J. F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00019-9 · Cited by 230
Self-citation
Research works printed but not linked: 1
- Smith, P.H., Wright, J.F., Qu, G., Patarroyo-White, S., Parker, A., and Sommer, J.M. (2003). Packaging of host cell and plasmid DNA into recombinant adeno-associated virus vectors produced by triple transfection. Mol. Ther. 7, S348.
Cited by
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Sharma, R., Anguela, X. M., Doyon, Y., Wechsler, T., DeKelver, R. C., Sproul, S., Paschon, D. E., Miller, J. C., Davidson, R. J., Shivak, D., et al. (2015) · Blood · doi:10.1182/blood-2014-12-615492 · Cited by 297
“AAV vectors used in Figures 1 and 2 and supplemental Figures 2B-D and 3 were produced and titered as previously described.(17,18) Experiments in Figures 3 and 4, and in supplemental Figures 1, 2A, and 5were conducted by usingAAV vectors prepared by triple-transfection of 293 cells in 10-layer CellSTACK chambers (Corni…”
MethodProgress and challenges in viral vector manufacturing
van der Loo, J. C. M., & Wright, J. F. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv451 · Cited by 255
“AAV vector-specific analytical methods and QC tests have had to be developed to address the complexity and unique features of vector product-related impurities in recombinant AAV investigational products (115).”
MethodSelf-citationGimpel, A. L., Katsikis, G., Sha, S., Maloney, A. J., Hong, M. S., Nguyen, T. N. T., Wolfrum, J., Springs, S. L., Sinskey, A. J., Manalis, S. R., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2021.02.010 · Cited by 185
Robust ZFN-mediated genome editing in adult hemophilic mice
Anguela, X. M., Sharma, R., Doyon, Y., Miller, J. C., Li, H., Haurigot, V., Rohde, M. E., Wong, S. Y., Davidson, R. J., Zhou, S., et al. (2013) · Blood · doi:10.1182/blood-2013-04-497354 · Cited by 178
Pharmacology of Recombinant Adeno-associated Virus Production
Penaud-Budloo, M., François, A., Clément, N., & Ayuso, E. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.01.002 · Cited by 177
“For the transient transfection method, less than 100 ng of residual plasmid DNA, as determined by antibiotic-resistance gene-targeted qPCR, is advised per 1 10(12) vg in the purified bulk product.(60) However, without associated risk assessment studies, it would be recommended to inquire about the proportion of each p…”
Background
Metadata
- Authors
- Wright, J. F., & Zelenaia, O.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Corresponding author
- Wright, J. Fraser
- ORCID
- Wright, J. Fraser
- Venue
- Methods in Molecular Biology
- Publisher
- Humana Press
- Published
- 2011
- Volume
- 737
- Pages
- 247-278
- ISSN
- 1064-3745 (ISSN-L)
- 1940-6029
- OpenAlex
- W2403540353
- Cited by
- 34
- References
- 22
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 1 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 1 · 2015: 4 · 2013: 3 · 2012: 1
- FWCI
- 4.08
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Methods in molecular biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (268200748203C)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- adeno-associated virus vectors, recombinant adeno-associated virus, quality control testing, gene therapy vectors, vector characterization, vector safety
- MeSH terms
- Dependovirus, Cell Line, Clinical Trials as Topic, DNA, Recombinant, Electrophoresis, Polyacrylamide Gel, Genetic Vectors, Humans, Reference Standards, Safety, Transduction, Genetic, Virion, Genetic Therapy, Polymerase Chain Reaction, Genome, Viral, Titrimetry, Guidelines as Topic, Cell Culture Techniques, Workflow
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vector Characterization Methods for Quality Control Testing of Recombinant Adeno-Associated Viruses. https://app.cochat.ai/papers/10.1007/978-1-61779-095-9_11
- The paper
- Wright, J. F., & Zelenaia, O. (2011). Vector Characterization Methods for Quality Control Testing of Recombinant Adeno-Associated Viruses. Methods in Molecular Biology. https://doi.org/10.1007/978-1-61779-095-9_11
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.